Navigation Links
GenVault Corporation Launches its Latest Centralized and Standardized Software Solution for Biobanking and Biological Sample Management, GenConnect 3.2

NEW YORK, April 21 /PRNewswire/ -- GenVault, a leading provider of room-temperature biosample transport, storage and management technologies, announced the release today of GenConnect 3.2, the newest version of its software for complete biosample management. Highlights of the release include a strategic licensing model that enables GenConnect to be integrated seamlessly into third-party informatics offerings, as well as a new customer licensing model that enables scalable enterprise-wide deployment that can be centrally administered.

GenConnect 3.2 supports the tracking of individual samples -- with either GenVault's own GenTegra(TM) tubes for purified DNA stored at room temperature, or generic tubes and vials stored in the frozen state - throughout the storage, retrieval and transport lifecycle. All data associated with storage locations and samples can be batch-uploaded to the database with a single click, making GenConnect an ideal solution for enterprise sites that need to process thousands of sample aliquots per day.

"With its rich JAVA-based API, language-independent Web Services interface, and standardized flat-file import/export capabilities, GenConnect can be seamlessly integrated with any upstream or downstream informatics packages and databases. The latest example of this is the integration of GenConnect 3.2 to GenoLogics' Biomedical Informatics product suite, as a part of our continuing partnership with GenoLogics to enable turnkey solutions for clinical and discovery research," said Dr. Dipesh Risal, Senior Product Manager for Software at GenVault. "GenConnect's client-server architecture allows for enterprise-level multi-site deployments, enabling both inter- and intra-institution connectivity; further, strict and tiered access controls built into the software means that entire networks of end-users can be administered from a centralized location. With this release, we are also rolling out a simple yet scalable licensing model that enables our customers to start small, with the option to scale-up and add more users as they derive greater value from the software."

GenConnect can accommodate the full spectrum of storage units used in biobanking, from traditional containers such as freezers and liquid nitrogen tanks, to the space saving, energy-efficient room-temperature storage options provided by GenVault. Stringent QA controls are built into the software for all Project, Subject and Sample-level data entry.

About GenVault

GenVault is a Global provider of cutting-edge technologies, for the acquisition, transportation and storage of biospecimens at ambient temperature, in the dry-state. GenConnect software, used to manage these technologies, can also be used with traditional cryogenic systems to enable mixed-phase sample management.

GenVault's technologies are environmentally friendly, space efficient alternatives to traditional sample storage systems. They reduce the carbon footprint of labs and significantly reduce energy consumption.

GenVault's systems are currently empowering over 150 pharmaceutical companies, medical centers and academic research institutions to sustainably leverage the rapidly growing genomics industry.

For more information, visit

Available Topic Expert: For information on the listed expert, click appropriate link.

Dipesh Risal

CONTACT: Bret Dash, 760-268-5242,

SOURCE GenVault Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. GenVault Partnership with Genome Quebec Brings $3.3 Million Sale of Dynamic Archive Product
2. David Barker, Former Illumina CSO, Joins GenVaults Scientific Advisory Board
3. GenVault and the National Center for Forensic Science to Present Novel Technology for Room Temperature Storage of RNA
4. McGill University Purchases GenVaults Personal Archive System to Manage Rare Cancer Samples
5. Mark Ostrowski Joins GenVault as Vice President of Sales and Marketing
6. Paul J. Mirabella, President and CEO of Naviscan PET Systems Inc., Joins GenVaults Board of Directors
7. GenVault Expands Scientific Advisory Board
8. GenVault Corporation Launches GenTegra(TM) DNA
9. Mark Sutherland Joins GenVault as Senior Vice President, Business Development
10. GenVault to Present at the BIOCOM Investor Conference
11. GenVault Opens Japanese Subsidiary to Better Address Global Biobanking Market Growth
Post Your Comments:
(Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... ... operations for Amgen, will join the faculty of the University of North ... adjunct professor of strategy and entrepreneurship at UNC Kenan-Flagler, with a focus on ...
(Date:6/24/2016)... June 24, 2016  Regular discussions on a range of ... between the two entities said Poloz. Speaking at ... Ottawa , he pointed to the country,s inflation target, ... government. "In certain ... institutions have common economic goals, why not sit down and ...
(Date:6/24/2016)... ... , ... Researchers at the Universita Politecnica delle Marche in Ancona combed medical ... mesothelioma. Their findings are the subject of a new article on the Surviving Mesothelioma ... in the blood, lung fluid or tissue of mesothelioma patients that can help point ...
(Date:6/23/2016)... Mass. , June 23, 2016   ... development of novel compounds designed to target cancer ... napabucasin, has been granted Orphan Drug Designation from ... the treatment of gastric cancer, including gastroesophageal junction ... stemness inhibitor designed to inhibit cancer stemness pathways ...
Breaking Biology Technology:
(Date:5/16/2016)... , May 16, 2016   EyeLock LLC , ... announced the opening of an IoT Center of Excellence ... and expand the development of embedded iris biometric applications. ... level of convenience and security with unmatched biometric accuracy, ... identity aside from DNA. EyeLock,s platform uses video technology ...
(Date:4/28/2016)... April 28, 2016 First quarter 2016:   ... 966% compared with the first quarter of 2015 The ... 589.1 M (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) ... guidance is unchanged, SEK 7,000-8,500 M. The operating margin ...
(Date:4/15/2016)... 15, 2016 Research and ... Biometrics Market 2016-2020,"  report to their offering.  , ... , ,The global gait biometrics market is expected ... the period 2016-2020. Gait analysis generates ... be used to compute factors that are not ...
Breaking Biology News(10 mins):